{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:44:49Z","timestamp":1791481489121,"version":"4.3.4"},"reference-count":22,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":173,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2001,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background and Aims:<\/jats:bold> Treatment with intravenous glycyrrhizin reduces the progression of liver disease caused by chronic hepatitis C (HCV) infection. Glycyrrhetinic acid, a metabolite of glycyrrhizin, inhibits the renal conversion of cortisol to cortisone by inhibiting the enzyme 11\u03b2\u2010hydroxysteroiddehydrogenase in the kidney. The resulting excess of cortisol subsequently stimulates the mineralocorticoid receptor, leading to pseudo\u2010aldosteronism with hypertension, hypokalemia and eventually renin and aldosterone suppression. The aim of this study was to evaluate the occurrence of pseudo\u2010aldosteronism after treatment of chronic hepatitis C (HCV) patients with increasing doses of intravenous glycyrrhizin.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Forty\u2010four HCV patients with chronic hepatitis or compensated cirrhosis were treated with intravenous glycyrrhizin 6 \u00d7 200 mg\/week, 3 \u00d7 240 mg\/week or 3 \u00d7 0 mg\/week (placebo) for 4 weeks. In all patients, bodyweight, blood pressure and plasma concentrations of sodium, potassium, cortisol, DHEA\u2010S (dehydroepiandrosterone sulfate), renin and aldosterone were measured before, and at 0 and 4 weeks after treatment.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Within the placebo group, no significant changes were observed. Within the 1200 mg group systolic blood pressure was significantly higher at the end of treatment, while aldosterone was significantly lower; at the end of the follow\u2010up period these values had returned to baseline. The changes from baseline in systolic and diastolic blood pressure at the end of treatment were significantly higher in the 1200 mg group compared to the placebo group. The changes in aldosterone and potassium concentrations at the end of treatment increased with increasing dosage, although not significantly.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Hepatitis C virus patients with chronic hepatitis or compensated cirrhosis show minor reversible symptoms of pseudo\u2010aldosteronism after treatment with 1200 mg glycyrrhizin weekly for 4 weeks.<\/jats:p>","DOI":"10.1046\/j.1440-1746.2001.02382.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T05:20:13Z","timestamp":1047446413000},"page":"789-795","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["\u2018Pseudo\u2010aldosteronism\u2019 induced by intravenous glycyrrhizin treatment of chronic hepatitis C patients"],"prefix":"10.1111","volume":"16","author":[{"given":"Tekla GJ Van","family":"Rossum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank H","family":"De Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim CJ","family":"Hop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans","family":"Boomsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solko W","family":"Schalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-4-431-68255-4_173"},{"key":"e_1_2_6_3_2","first-page":"423","article-title":"Effects of glycyrrhizin on biochemical tests in patients with chronic hepatitis.","volume":"26","author":"Suzuki H","year":"1983","journal-title":"Asian Med. J."},{"key":"e_1_2_6_4_2","first-page":"1093","article-title":"Intravenous glycyrrhizin for the treatment of chronic hepatitis C. A double\u2010blind placebo\u2010controlled randomized trial.","volume":"14","author":"Rossum TGJ","year":"1999","journal-title":"J. Gastroenterol."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(91)90210-V"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(96)00163-8"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/07435809509030454"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/jama.1968.03140330034006","article-title":"Licorice\u2010induced pseudoaldosteronism. Hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity.","volume":"205","author":"Conn JW","year":"1968","journal-title":"JAMA"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)91014-2"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-40-6-1038"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1993.tb01195.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.5.2.244"},{"key":"e_1_2_6_14_2","first-page":"1207","volume-title":"Module 5V.","author":"Dixon W.J.","year":"1990"},{"key":"e_1_2_6_15_2","unstructured":"MensingaTJT SipsAJAM Van Den HamW MeulenbeltJ.Health risks due to consumption of liquorice.RIVM rapport 236850003;1998(on\u2010line).http:\/\/www.rivm.nl\/lib\/Reports\/236850003.html."},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(19)32472-2"},{"key":"e_1_2_6_17_2","first-page":"137","article-title":"Hypokalaemia induced by thiazide diuretics in the treatment of hypertension: a cause for concern, not nihilism.","volume":"59","author":"Poole\u2010Wilson PA.","year":"1983","journal-title":"Postgrad. Med. J."},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196603172741104"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6089.738-a"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01497780"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)92495-4"},{"key":"e_1_2_6_22_2","first-page":"389","article-title":"Arrhytmieausl\u00f6sung durch Lakritzabusus.","volume":"80","author":"Bocker D","year":"1991","journal-title":"Z. Kardiol."},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70645-6"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1440-1746.2001.02382.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1440-1746.2001.02382.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T15:32:46Z","timestamp":1697643166000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1440-1746.2001.02382.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["10.1046\/j.1440-1746.2001.02382.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1440-1746.2001.02382.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7]]},"assertion":[{"value":"2001-12-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}